We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

UBS analyst Matthew Weston downgraded Novartis (SIX:NOVN) shares from Buy to Neutral and reduced the price target from CHF111 ...

瑞士制药巨头 诺华 （Novartis）周二表示，已同意以至多30.8亿美元的价格收购美国私人控股的临床阶段生物制药公司Anthos Therapeutics，以扩大其心血管药物管线。

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against other best annual dividend stocks to buy now. In 2025, dividends in MSCI Europe are expected to reach a ...

Novartis AG (NYSE:NVS) stock has climbed 10% year-to-date as of February 7, 2025. On December 10, 2024, Novartis AG (NYSE:NVS) shared new results from the Phase III NATALEE trial, showing that ...

NVS is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. NVS has a Momentum Style Score of B, and shares are up 9.6% over the past ...

Novartis’ efforts to strengthen its wide portfolio ... For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% ...

comprising an upfront payment and potential additional milestone payments. Price Action: NVS stock is down 0.31% at $106.52 during the premarket session on last check Tuesday.